Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Provision of Patient Services

Sponsored by

Finalist

"touch" Patient Support Programme

LEO Pharma in association with Atlantis Healthcare


Summary of work

In the UK, approximately 1.2 million people have psoriasis, a chronic condition, which can often cause feelings of low-esteem, depression and social isolation. Furthermore, 40 per cent of patients prescribed a topical treatment do not use it as prescribed. 

In conjunction with health psychologists, dermatologists and patients, LEO Pharma has therefore developed “touch” – an evidence-based support programme designed to improve adherence and health outcomes for people living with psoriasis. 

Available to everyone with psoriasis aged over 18 in the UK (and their loved ones); users can access the touch website and helpline, and also receive belief-based interventional content through a variety of media channels. 

touch aims to improve members’ beliefs about their treatment and condition, by offering tailored support and coping strategies to encourage better disease self-management. An interim measurement sample shows the programme has reduced by over 85 per cent (exceeding objective of 70 per cent) the number of interviewees holding unhelpful beliefs, identified in the research as key predictors of non-adherence.

Launched in April 2011, touch currently supports 7,056 members.

 

 

Executive summary as submitted


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics